State of New Jersey Common Pension Fund D’s Corvus Pharmaceuticals CRVS Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Buy	+20,369	New	+$283K	﹤0.01%	1672

Other funds holding CRVS

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FMI

F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

TowerView LLC New York $152M AUM 20.28% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CRVS Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Corvus Pharmaceuticals (CRVS) in Q2 2026: 20,369 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #1672 among its holdings.

42 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

State of New Jersey Common Pension Fund D held 20,369 shares of Corvus Pharmaceuticals worth $304K as of Q2 2026.
Corvus Pharmaceuticals was a new State of New Jersey Common Pension Fund D position in Q2 2026.
Corvus Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1672 holding.
42 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.